Editor's Picks Analysis & Opinion

A number of health-care and biotech shares have recently been in the spotlight. In early October, Merck (NYSE:MRK)—covered in early November—gave a positive update on molnupiravir, a...

It lasted a month but gold in $1,800 territory now looks increasingly vulnerable, with bears appearing set to attack the base support for the perch.It’s a dramatic reversal of sentiment by...

The decision by US President Joseph Biden to nominate Jerome Powell for a second term as chair of the Federal Reserve—when it finally came on Monday—was widely expected. But there was...

For some retirees, technology is a no-go area due to the sector’s volatile nature and its inability to provide cash flows in the form of dividends.But the COVID-19 pandemic has proved that...

Long-term investors in Chinese shares have had a volatile year so far in 2021. The state’s heavy hand on technology, online education and real estate names meant significant pressure for those...

Anticipation of an OPEC strike back against oil bears and intrigue over President Joseph Biden’s plans for Fed Chief Jerome Powell’s job could result in price swings in crude and gold this...

Lowe’s (LOW) has posted incredible gains in 2021 House price acceleration encourages people to spend on their home COVID and working from home also boosts spending on home improvement Shares...

Dow-30 member Johnson & Johnson is up 3.4% so far in 2021, but down about 9.2% in the past three months. JNJ recently announced it will spin off the consumer health division Despite potential...